Methotrexate alpha-monobutyl ester

ID: ALA3245814

Chembl Id: CHEMBL3245814

Cas Number: 66147-30-6

PubChem CID: 90672327

Max Phase: Preclinical

Molecular Formula: C24H30N8O5

Molecular Weight: 510.56

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCOC(=O)[C@H](CCC(=O)O)NC(=O)c1ccc(N(C)Cc2cnc3nc(N)nc(N)c3n2)cc1

Standard InChI:  InChI=1S/C24H30N8O5/c1-3-4-11-37-23(36)17(9-10-18(33)34)29-22(35)14-5-7-16(8-6-14)32(2)13-15-12-27-21-19(28-15)20(25)30-24(26)31-21/h5-8,12,17H,3-4,9-11,13H2,1-2H3,(H,29,35)(H,33,34)(H4,25,26,27,30,31)/t17-/m0/s1

Standard InChI Key:  ACDMHLAVMTZWNJ-KRWDZBQOSA-N

Associated Targets(Human)

CCRF-CEM (65223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Serum (1292 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Dihydrofolate reductase (4 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 510.56Molecular Weight (Monoisotopic): 510.2339AlogP: 1.53#Rotatable Bonds: 12
Polar Surface Area: 199.54Molecular Species: ACIDHBA: 11HBD: 4
#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 6#RO5 Violations (Lipinski): 3
CX Acidic pKa: 4.05CX Basic pKa: 2.96CX LogP: 1.47CX LogD: -1.66
Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.20Np Likeness Score: -0.56

References

1. Rosowsky A, Beardsley GP, Ensminger WD, Lazarus H, Yu CS..  (1978)  Methotrexate analogues. 11. Unambiguous chemical synthesis and in vitro biological evaluation of alpha- and gamma-monoesters as potential prodrugs.,  21  (4): [PMID:565818] [10.1021/jm00202a013]

Source